Portfolio Company Exit

Represented a prominent venture capital firm in connection with insurance coverage issues arising out of a medical device portfolio company exit.  Post-closing, the acquiring company brought claims against the venture capital firm, to which the firm’s VCAP liability insurer initially denied coverage.  Following our involvement, the venture capital firm obtained a substantial settlement contribution from its insurer.